DOXYCYCLINE 100mg. IP + AMBROXOL 7.5mg. IP

A dual-action drug (antibiotic and mucolytic) that treats both acute and chronic respiratory diseases. An effective secretolytic and mucoactive agent for the treatment of respiratory diseases associated with viscid mucus. (Dorotheea Cazan, 2018) A long-acting bacteriostatic antibiotic that blocks protein biosynthesis required for bacterial cell growth. (Claudio Conforti, 2020) Stimulates the secretion of phlegm adhered to the surface of the respiratory tract. (Xiaoxia Du, 2020) A potent antimicrobial with both antiviral and anti-inflammatory activities. (Ismail Anwar, 2020) Alleviates cough, and sputum in patients with respiratory tract infections. (Titscher, 1975) Dilutes the phlegm and makes breathing easier in asthma and chronic obstructive pulmonary disease patients. Reduces congestion and allows the patient to breathe deeply and freely. A valuable drug for patients with bronchial asthma and spastic bronchitis. Possesses a bacteriostatic activity against a wide variety of pathogens and prevents infection. (Smilack, 1999) An effective therapeutic choice for treating asthmatic bronchitis as it effectively controls the disease condition and relieves symptoms. (Xiaoxia Du, 2020)